SCHEMBL2345558

SCHEMBL2345558

CCCCCCCCCO[Sn](CCCC)(CCCC)O[Sn](CCCC)(CCCC)OCCCCCCCCC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 1/20 0.35
CA1 P00915 8/20 0.34
CA2 P00918 8/20 0.34
CA9 Q16790 7/20 0.34
LPAR3 Q9UBY5 6/20 0.34
LPAR2 Q9HBW0 5/20 0.34
CA12 O43570 3/20 0.34
CA7 P43166 3/20 0.34
CA14 Q9ULX7 3/20 0.34
LPAR1 Q92633 2/20 0.34
CA3 P07451 2/20 0.34
CA4 P22748 2/20 0.34
CA6 P23280 2/20 0.34
CA5A P35218 2/20 0.34
CA5B Q9Y2D0 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2345785 1.00 THRB (0.36) THRBTSHRMEN1HTTKMT2A
SCHEMBL2341466 1.00 THRB (0.36) THRBTSHRMEN1HTTKMT2A
SCHEMBL473105 1.00 THRB (0.36) THRBTSHRMEN1HTTKMT2A
SCHEMBL2347740 1.00 THRB (0.36) THRBTSHRMEN1HTTKMT2A
SCHEMBL7884098 1.00 THRB (0.36) THRBTSHRMEN1HTTKMT2A
SCHEMBL10543049 1.00 THRB (0.36) THRBTSHRMEN1HTTKMT2A
SCHEMBL2345671 1.00 THRB (0.36) THRBTSHRMEN1HTTKMT2A
SCHEMBL2348389 0.98 CA1 (0.32) THRBTSHRMEN1HTTKMT2A
SCHEMBL2339612 0.96 THRB (0.33) THRBTSHRMEN1HTTKMT2A
SCHEMBL2344120 0.96 THRB (0.33) THRBTSHRMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1535896-B1 PROCESS FOR PRODUCING CARBONIC ESTER ASAHI KASEI CHEMICALS CORP (JP) 2015-10-07 EP disclosed
EP-1760085-B1 PROCESS FOR PRODUCTION OF ALKYLTIN ALKOXIDES ASAHI KASEI CHEMICALS CORP (JP) 2014-02-26 EP disclosed
EP-1640357-B1 METHOD FOR PRODUCING AROMATIC CARBONATE ASAHI KASEI CHEMICALS CORP (JP) 2011-08-31 EP disclosed
US-7652122-B2 Method for producing an aromatic carbonate ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-01-26 US disclosed
US-7541482-B2 Process for production of alkyltin alkoxides ASAHI KASEI CHEMICALS CORPORATION (JP) 2009-06-02 US disclosed
US-20080275262-A1 Process for Production of Alkyltin Alkoxides ASAHI KASEI CHEMICALS CORPORATION (JP) 2008-11-06 US disclosed
US-7446218-B2 Process for producing carbonic ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2008-11-04 US disclosed
US-20070055042-A1 Method for producing an aromatic carbonate ASAHI KASEI KABUSHIKI KAISHA (JP) 2007-03-08 US disclosed
EP-1760085-A1 PROCESS FOR PRODUCTION OF ALKYLTIN ALKOXIDES Asahi Kasei Chemicals Corporation (JP) 2007-03-07 EP disclosed
EP-1640357-A1 METHOD FOR PRODUCING AROMATIC CARBONATE Asahi Kasei Chemicals Corporation (JP) 2006-03-29 EP disclosed
US-20050240045-A1 Process for producing carbonic ester ASAHI KASEI KABUSHIKI KAISHA (JP) 2005-10-27 US disclosed
EP-1535896-A1 PROCESS FOR PRODUCING CARBONIC ESTER Asahi Kasei Chemicals Corporation (JP) 2005-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050240045-A1 Process for producing carbonic ester ALKBH3, CYP4A11, CYP2E1 THRB 1962/4885TSHR 2565/4885MEN1 1171/4885
US-20080275262-A1 Process for Production of Alkyltin Alkoxides ALK, MOGAT2, SOAT2 THRB 342/4885TSHR 349/4885MEN1 2854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.